SLS compared with ULS: revenue, margins and what each company keeps, and the suppliers and customers both name

SLSSELLAS Life Sciences Group, Inc.

Mkt capRevenueRevenue

ULSUL Solutions Inc.

Mkt capRevenueRevenue

Compare

SLSSELLAS Life Sciences Group, Inc.

ULSUL Solutions Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

SLS

2 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.4%▲+6.52%×0.69

May 13 '26±7.9%▲+25.10%×3.18

Q1 FY26±5.8%▼−8.46%×1.47

Jan 8 '26±9.6%▼−4.46%×0.47

ULS2 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±9.0%▲+7.00%×0.78

Q2 FY26—▼−13.96%—

= impliedSLS realized, solidULS realized, hatchedOne scale, both sides: full bar = 26%× = |realized| ÷ impliedspan: SLS 216d · ULS 91dSource: market data

SLSSELLAS Life Sciences Group, Inc.

8.41▲+6.73%· post 8.33

Mkt cap$1.7BRevenue—Revenue—

ULSUL Solutions Inc.

78.72▲+3.37%· post 78.72

ClosedNov 6 '26

Mkt cap$15.9BRevenue$823MQ3 FY26Revenue$3.1BFY25

Compare

ClosedNov 6 '26

SLSSELLAS Life Sciences Group, Inc.

ULSUL Solutions Inc.

8.41▲+6.73%post 8.33

Price

78.72▲+3.37%post 78.72

$1.7B

Mkt cap

$15.9B

—

Revenue

$823MQ3 FY26

—

Revenue

$3.1BFY25

SLS8.41▲+6.73%vsULS78.72▲+3.37%ClosedNov 6 '26